Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript
Intelligent Bio Solutions Inc INBS
$1.63
▼ -1.21%
($-0.02)
⬆️ Above Yest. High
🎈 Low Float
🎢 High Beta
Open
$1.72
Prev Close
$1.65
Day Range
$1.60 – $1.72
52W Range
$1.52 – $24.90
Market Cap
$5.41M
Beta
4.56
EPS (TTM)
$-9.66
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-23 |
| Shares Out. | 2,390,000 |
| Website | ibs.inc/ ↗ |
| Phone | 13025750877 |
| Employees | 60 |
| Revenue | $1.1M |
| Gross Profit | $536,583 |
| Net Income | -$3.9M |
| Free Cash Flow | -$12.1M |
| Total Assets | $11.9M |
| Total Liabilities | $6.7M |
| Equity | $5.3M |
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
Intelligent Bio Solutions Inc is a publicly traded company under the ticker symbol INBS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-09-01)